SEK2 (MKK4/MAP2K4): A Master Regulator of MAPK Signaling in Stress, Inflammation and Disease

SEK2 (MKK4/MAP2K4): A Master Regulator of MAPK Signaling in Stress, Inflammation and Disease

SEK2 (MKK4/MAP2K4): A Master Regulator of MAPK Signaling in Stress, Inflammation and Disease

A Scientific Review by ANT BIO PTE. LTD.

Image Position

Concept

SEK2 (also known as MKK4 or MAP2K4) is a dual‑specificity kinase that functions as a core signal transducer in the mitogen‑activated protein kinase (MAPK) cascade. This 44 kDa protein selectively activates the JNK pathway while showing moderate activity toward p38, making it indispensable for cellular stress responses, inflammatory signaling, cell fate determination, and tissue homeostasis.

Research Frontiers

Recent structural and biochemical studies have revealed that the unique conformation of the SEK2 activation loop underpins its strict substrate preference for JNK over p38 or ERK. This kinase is tightly controlled via multi‑layer post‑translational modifications, including phosphorylation, ubiquitination, and acetylation, which govern its activity, stability, subcellular localization, and protein–protein interactions. Dynamic shuttling between the cytoplasm, nucleus, and organelles allows SEK2 to orchestrate spatially and temporally distinct signaling outputs in response to stress, cytokines, and oncogenic signals.

Research Significance

SEK2 serves as a critical signaling node that connects upstream stress signals to downstream gene expression and cellular responses. Dysregulation of the SEK2‑JNK axis is implicated in a wide spectrum of pathological conditions, including chronic inflammatory diseases, neurodegeneration, metabolic disorders, and cancer progression. As such, SEK2 represents a promising diagnostic biomarker and a tractable therapeutic target for precision medicine and drug development.

Related Mechanisms and Research Applications

SEK2 is activated via phosphorylation at Ser257 and Thr261 by upstream MAP3Ks, including ASK1 and MEKK1‑4. Once activated, SEK2 specifically phosphorylates JNK at Thr183 and Tyr185 to trigger full kinase activity. This signaling axis is stabilized and spatially organized by JIP family scaffold proteins, ensuring signaling fidelity and efficiency.

Common research applications for studying SEK2 include:

  • Western blotting for expression and post‑translational modification analysis
  • Immunofluorescence staining for subcellular localization
  • Flow cytometry for signaling dynamics in immune cells
  • Immunoprecipitation for protein–protein interaction studies
  • Kinase activity assays for drug screening and inhibitor development

ANTBIO’s Brand Mission

At ANT BIO PTE. LTD., we are dedicated to accelerating life science research and translational discovery by developing high‑quality, rigorously validated antibodies, recombinant proteins, and assay kits tailored to the MAPK signaling pathway. Our innovative product portfolio empowers scientists worldwide to explore fundamental biological mechanisms and translate scientific insights into clinical applications.

Related Product Portfolio

  • SEK2/MKK4 rabbit polyclonal antibody (Cat#: A‑AB‑12987)
  • Phospho‑SEK2 (Ser257/Thr261) mouse monoclonal antibody (Cat#: A‑AB‑12988)
  • JIP1 scaffold protein antibody (Cat#: A‑AB‑12989)
  • Recombinant human active SEK2 protein (Cat#: A‑PRO‑0764)
  • SEK2/JNK signaling pathway ELISA kit (Cat#: A‑KIT‑0957)
  • MAPK family antibody sampler kit (Cat#: A‑KIT‑0958)

Brand Promotion

ANT BIO PTE. LTD. – Empowering Scientific Breakthroughs

At ANTBIO, we are committed to advancing life science research through high-quality, reliable reagents and comprehensive solutions. Our specialized sub-brands (Absin, Starter, UA) cover a full spectrum of research needs, from general reagents and kits to antibodies and recombinant proteins. With a focus on innovation, quality, and customer-centricity, we strive to be your trusted partner in unlocking scientific mysteries and driving medical progress. Explore our product portfolio today and elevate your research to new heights.